Skip to main content
. Author manuscript; available in PMC: 2015 Jun 1.
Published in final edited form as: Stroke. 2014 May 13;45(6):1791–1798. doi: 10.1161/STROKEAHA.113.003874

Table 1.

Hospital Charges as Incurred, Costs as Incurred, and Costs in 2012 US Currency for the Initial Treatment of US Patients with Moderate or Severe Stroke Enrolled in the Study

Treatment
Group
Charges
(Year of Stroke*)
Costs
(Year of
Stroke*)
Present Value
Costs
(2012 Value)
Estimated
Mean 2012
Cost**

Endovascular Therapy:
  Mean (SD) $113,185 (82,797) $31,074 (18,756) $35,175 (20,702) $35,130
  Median (Range) $86,481 (23,350–552,279) $26,935 (6,602–179,491) $29,848 (7,856–205,609)

IV t-PA Alone:
  Mean (SD) $86,880 (91,057) $23,833 (21,799) $26,266 (24,042) $25,630
  Median (Range) $58,247 (13,701–830,652) $18,134 (6,602–179,491) $19,768 (5,992–209,299)

No physician charges are included in the estimates.

IV = intravenous; t-PA = tissue plasminogen activator;

*

Costs in year of stroke indicates the actual costs at the time of patient enrollment. These costs are not adjusted for inflation.

**

Multivariable model controlling for age, NIHSS, time to IV t-PA administration, stroke location and diabetes.